Cancer Controversy: Amish couple in court over daughter's chemot - KPTV - FOX 12

Cancer Controversy: Amish couple in court over daughter's chemotherapy treatment

Posted: Updated:

A battle over the best medical treatment for a 10-year old Amish girl is underway in Akron.

The child found out she had cancer in April. A few days later she started treatment at Akron Children's Hospital.

"The prognosis for the 10-year old girl was pretty favorable, 85% chance of remission. We thought that she needed to continue chemotherapy," said Robert McGregor the Chief Medical Officer at Akron Children's Hospital.

The 10-year old girl received one round of treatment at Akron Children's Hospital for bone and lymphoma cancer, then she and her family decided to go the natural medicine route. Hospital officials tell us the decision had nothing to do with religion.

"A 10 year old cognitively is not in a state of really making decisions that go beyond here and now. This is uncomfortable, I don't want to do it as opposed to this is uncomfortable it's going to get me to 15," said McGregor.

The hospital's ethics committee made sure that the family wanted to stop the chemotherapy. That's when Akron Children's Hospital took the case to Children Services who didn't want to act on it.

The hospital's next step asking for a court appointed guardian.

"See if that court guardian would come up with that same decision as the family or the decision that we had made," said McGregor.

The judge refused guardianship saying the parents were capable of making medical decisions on their daughter's behalf. That's when the hospital filed an appeal a few weeks ago.

"There was a very good chance that this little girl could be 15-years old," said McGregor.

The judge in this case will make a final decision in a week. Until then, the child has been ordered to continue therapy.

Copyright 2013 WOIO. All rights reserved.

Powered by WorldNow
FOX 12
Powered by WorldNow CNN
All content © 2014, KPTV-KPDX Broadcasting Corporation, Portland, OR and WorldNow. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.